
Zomedica Corp. – AMEX:ZOM
Zomedica Corp. stock price today
Zomedica Corp. stock price monthly change
Zomedica Corp. stock price quarterly change
Zomedica Corp. stock price yearly change
Zomedica Corp. key metrics
Market Cap | 118.18M |
Enterprise value | 182.94M |
P/E | -10.7 |
EV/Sales | 6.79 |
EV/EBITDA | -9.77 |
Price/Sales | 7.78 |
Price/Book | 0.78 |
PEG ratio | -0.16 |
EPS | -0.01 |
Revenue | 4.13M |
EBITDA | -19.84M |
Income | -18.38M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -97.39% |
Oper. margin | -119.27% |
Gross margin | 72.23% |
EBIT margin | -119.27% |
EBITDA margin | -480.25% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeZomedica Corp. stock price history
Zomedica Corp. stock forecast
Zomedica Corp. financial statements
Mar 2021 | 14.12K | -4.03M | -28581.26% |
---|---|---|---|
Jun 2021 | 15.69K | -4.71M | -30017.68% |
Sep 2021 | 22.51K | -6.34M | -28185.52% |
Dec 2021 | 4.08M | -3.28M | -80.62% |
2027 | 56.92M | 9.79M | 17.22% |
---|
Analysts Price target
Financials & Ratios estimates
Mar 2022 | 277990000 | 8.94M | 3.22% |
---|---|---|---|
Jun 2022 | 275478000 | 9.25M | 3.36% |
Sep 2022 | 282299000 | 13.51M | 4.79% |
Dec 2022 | 279610000 | 12.21M | 4.37% |
Mar 2021 | -2.63M | -18.02K | 217.26M |
---|---|---|---|
Jun 2021 | -1.73M | -123.25K | 1.47M |
Sep 2021 | -4.99M | -201.02K | 400K |
Dec 2021 | -4.90M | -71.58M | 23K |
Zomedica Corp. alternative data
Aug 2023 | 85 |
---|---|
Sep 2023 | 85 |
Oct 2023 | 85 |
Nov 2023 | 85 |
Dec 2023 | 85 |
Jan 2024 | 85 |
Feb 2024 | 85 |
Apr 2024 | 85 |
May 2024 | 144 |
Jun 2024 | 144 |
Jul 2024 | 144 |
Zomedica Corp. other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 200000 | 0 |
May 2024 | 525000 | 0 |
Jun 2024 | 1025000 | 0 |
Aug 2024 | 200000 | 0 |
Sep 2024 | 100000 | 0 |
Nov 2024 | 850000 | 0 |
Quarter | Transcript |
---|---|
Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 1 Apr 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 13 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Stephanie Laine Morley D.V.M., DVM (1975) Consultant | $282,700 |
-
What's the price of Zomedica Corp. stock today?
One share of Zomedica Corp. stock can currently be purchased for approximately $0.1.
-
When is Zomedica Corp.'s next earnings date?
Unfortunately, Zomedica Corp.'s (ZOM) next earnings date is currently unknown.
-
Does Zomedica Corp. pay dividends?
No, Zomedica Corp. does not pay dividends.
-
How much money does Zomedica Corp. make?
Zomedica Corp. has a market capitalization of 118.18M.
-
What is Zomedica Corp.'s stock symbol?
Zomedica Corp. is traded on the AMEX under the ticker symbol "ZOM".
-
What is Zomedica Corp.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Zomedica Corp.?
Shares of Zomedica Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Zomedica Corp.'s key executives?
Zomedica Corp.'s management team includes the following people:
- Dr. Stephanie Laine Morley D.V.M., DVM Consultant(age: 50, pay: $282,700)
-
How many employees does Zomedica Corp. have?
As Jul 2024, Zomedica Corp. employs 144 workers, which is 69% more then previous quarter.
-
When Zomedica Corp. went public?
Zomedica Corp. is publicly traded company for more then 7 years since IPO on 21 Nov 2017.
-
What is Zomedica Corp.'s official website?
The official website for Zomedica Corp. is zomedica.com.
-
Where are Zomedica Corp.'s headquarters?
Zomedica Corp. is headquartered at 100 Phoenix Drive, Ann Arbor, MI.
-
How can i contact Zomedica Corp.?
Zomedica Corp.'s mailing address is 100 Phoenix Drive, Ann Arbor, MI and company can be reached via phone at +7 343692555.
Zomedica Corp. company profile:

Zomedica Corp.
zomedica.comAMEX
144
Drug Manufacturers - Specialty & Generic
Healthcare
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Ann Arbor, MI 48108
CIK: 0001684144
ISIN: CA98980M1095
CUSIP: 98980M109